Ironing out the phosphorus problem.

Publication/Presentation Date

5-1-2010

Abstract

Control of serum phosphorus remains a vexing problem in chronic kidney disease. Although novel dialysis regimens may provide excellent phosphorus control, phosphate binders remain necessary for most dialysis patients. Block et al. present a phase I clinical trial examining the safety and efficacy of SBR759, a novel non-calcium, iron-based phosphate binder. Although the risks of iron accumulation and hypocalcemia must be addressed, this phosphate binder appears to be well tolerated and effective and offers a powder-based formulation.

Volume

77

Issue

10

First Page

845

Last Page

847

ISSN

1523-1755

Disciplines

Medicine and Health Sciences | Pediatrics

PubMedID

20431575

Department(s)

Department of Pediatrics

Document Type

Article

Share

COinS